Our global CDMO capacities and services

The best-fit solution for your endeavor - Rentschler Development Services At Rentschler Biopharma, we are committed to being your strategic partner, providing not just solutions but also expert support that empowers your success and contribution to the treatment of serious and rare diseases. We recognize the importance of providing our clients with the best-fit solution to realizing their ideas and projects. Our Rentschler Development Services Program is a comprehensive framework aimed at tailoring development projects to clients’ particular needs and project stages. Our goal is to empower our clients by offering a range of tailored services. Whether you’re a startup or an established player, we understand that one size does not fit all. With the Development Services Program, you can choose from three different options: Velocity, Flexibility, and Liberty. Click to discover more Velocity Velocity is our fast-track service offering for clients who must be fast. With our fixed timelines, fixed prices and standardized processes , we reliably deliver released Drug Substance for your clinical Phase I/II project on-time. Click to discover more Flexibility Sometimes our clients require flexibility due to shifting priorities, unforeseen challenges, or changing market dynamics. Flexibility provides you with customized timelines and ensures that you can pivot, when necessary, without compromising quality independent of the clinical phase . Click to discover more Liberty For our clients who thrive on experimentation and innovation, Liberty offers you standalone activities and work packages to test hypotheses, fill a specific gap in your portfolio, iterate rapidly, and stay ahead of the wave . Click to discover more Interested? Then get in touch with our Business Development team at BIO International Convention or contact us via our website . | Reliability You Can Trust Rentschler Biopharma is a family-owned company with about 1,400 employees, headquartered in Laupheim, Germany, with operations in Milford, MA, USA. Multiple seed-train and upscale options Fed batch, n-1 perfusion and continuous processes Stainless steel bioreactors: 1 x 3,000 L, 2 x 3,000 L Single use bioreactors: 1 x 500 L, 3 x 1,000 L, 7 x 2,000 L Robust and scalable CHO cell line development platform Flexible purification platform for any protein format cGMP production for clinical and commercial supply and beyond At Rentschler Biopharma, reliability you can trust is more than a promise - it's our commitment. As a global leader in Contract Development and Manufacturing Organization (CDMO) services for biopharmaceuticals we take pride in our contributions to nearly 25% of FDA-approved biopharmaceuticals in 2023 alone. Fueled by 50 years of experience in biopharmaceutical manufacturing, we lead the charge in empowering tomorrow's therapies today. Our international state-of-the-art facilities and expert solutions for the most complex biopharmaceuticals ensure excellence at every stage of your product's journey - from concept to market.